| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1996;61:1400-1406
© 1996 The Society of Thoracic Surgeons
Departments of Cardiovascular Surgery and Pharmacology and Toxicology, University of Western Ontario, London, Ontario, Canada
Accepted for publication January 23, 1996.
Background. Na+/H+ exchange represents an important mechanism for pH regulation in the cardiac cell that, however, may paradoxically mediate tissue damage in the reperfused myocardium. We investigated whether inhibition of the exchanger can protect the heart against damage after prolonged hypothermic storage with the use of the selective inhibitor 3-methylsulfonyl-4-piperidinobenzoyl-guanidine methanesulfonate (HOE 694).
Methods. After equilibration, isolated rabbit hearts were arrested with a 3 minute infusion of modified St. Thomas' cardioplegic solution and subsequently maintained in ischemic arrest at 4°C for 12 hours before reperfusion at 37°C for 60 minutes. Left ventricular function and creatine kinase release were measured at intervals throughout reperfusion. High-energy phosphate and adenine nucleotide content were determined in hearts before cardioplegia, at the end of the 12-hour storage period, and at the end of reperfusion. HOE 694 (1 µmol/L) was administered either with cardioplegia and throughout reperfusion (study 1) or selectively with either cardioplegia or reperfusion only (study 2).
Results. In study 1, systolic function in untreated hearts recovered to less than 40% of preischemic values and was associated with a greater than 1,000% percent sustained elevation in left ventricular end-diastolic pressure. In contrast, systolic recovery in HOE 694-treated hearts was significantly accelerated and improved to approximately 80%, whereas left ventricular end-diastolic pressure increased to only 300% of baseline. Significant protection also occurred in those hearts in which HOE 694 was administered only at reperfusion while the drug was less effective if given only during cardioplegia. Creatine kinase release was not significantly affected except in study 2, where it was significantly lower after 60 minutes of reperfusion in hearts where HOE 694 was added at the time of reperfusion. Tissue metabolite content was not affected by drug treatment.
Conclusions. This study shows a marked protective effect of the Na+/H+ exchange inhibitor HOE 694 in rabbit hearts subjected to 12 hours of hypothermic ischemia and strongly suggests that antiport inhibitors could play an effective role in myocardial preservation.
This article has been cited by other articles:
|
|
 |
|
  J. S. Corvera, Z.-Q. Zhao, L. S. Schmarkey, S. L. Katzmark, J. M. Budde, C. D. Morris, T. Ehring, R. A. Guyton, and J. Vinten-Johansen Optimal dose and mode of delivery of Na+/H+ exchange-1 inhibitor are critical for reducing postsurgical ischemia-reperfusion injury Ann. Thorac. Surg., November 1, 2003; 76(5): 1614 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Muraki, C. D. Morris, J. M. Budde, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 155 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murashita and K. Yasuda The role of Na+/H+ exchange in the efficacy of multidose hypothermic cardioplegia in immature rabbit hearts Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 944 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. An, S. G. Varadarajan, A. Camara, Q. Chen, E. Novalija, G. J. Gross, and D. F. Stowe Blocking Na+/H+ exchange reduces [Na+]i and [Ca2+]i load after ischemia and improves function in intact hearts Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2398 - H2409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Knight, A. H. Smith, D. M. Flynn, J. T. MacAndrew, S. S. Ellery, J. X. Kong, R. B. Marala, R. T. Wester, A. Guzman-Perez, R. J. Hill, et al. A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 254 - 259. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Hoenicke, X. Sun, R. G. Strange Jr, and R. J. Damiano Jr Donor heart preservation with a novel hyperpolarizing solution: Superior protection compared with University of Wisconsin solution J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 746 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Spitznagel, O. Chung, Q.-G. Xia, B. Rossius, S. Illner, G. Jahnichen, S. Sandmann, A. Reinecke, M. J.A.P. Daemen, and T. Unger Cardioprotective effects of the Na+/H+-exchange inhibitor cariporide in infarct-induced heart failure Cardiovasc Res, April 1, 2000; 46(1): 102 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. Perrault and P. Menasche Preconditioning: can nature’s shield be raised against surgical ischemic-reperfusion injury? Ann. Thorac. Surg., November 1, 1999; 68(5): 1988 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Petrecca, R. Atanasiu, S. Grinstein, J. Orlowski, and A. Shrier Subcellular localization of the Na+/H+ exchanger NHE1 in rat myocardium Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H709 - H717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Myers, P. Farhangkhoee, and M. Karmazyn Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) Cardiovasc Res, November 1, 1998; 40(2): 290 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-I. L. Kim, P. Herijgers, S. K. Laycock, A. Van Lommel, E. Verbeken, and W. J. Flameng Na+/H+ exchange inhibition improves long-term myocardial preservation Ann. Thorac. Surg., August 1, 1998; 66(2): 436 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Tritto, J. Inserte, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler Sodium/Hydrogen Exchanger Inhibition Reduces Myocardial Reperfusion Edema After Normothermic Cardioplegia J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Frohlich and M. Karmazyn The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease Cardiovasc Res, November 1, 1997; 36(2): 138 - 148. [Full Text] [PDF]
|
|
|
|
|
|
I. O. Choy, V. D. Schepkin, T. F. Budinger, D. Y. Obayashi, J. N. Young, and W. M. DeCampli Effects of Specific Sodium/Hydrogen Exchange Inhibitor During Cardioplegic Arrest Ann. Thorac. Surg., July 1, 1997; 64(1): 94 - 99. [Abstract] [Full Text]
|
|
|
|
|
|
M. Karmazyn EDITORIAL: SODIUM-HYDROGEN EXCHANGE INHIBITION--SUPERIOR CARDIOPROTECTIVE STRATEGY J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 776 - 777. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
